Correspondence on ‘Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients’

By sjmartinez • September 21, 2023

Kermani TA. Correspondence on 'Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients'. Ann Rheum Dis. 2023 Oct;82(10):e214. doi: 10.1136/annrheumdis-2021-219879. Epub 2021 Jan 21. PMID: 33478954.

Tags: biological therapy, covid-19, Publications, Rheumatology, systemic vasculitis

Physical Activity, Genetic Susceptibility, and Risk of Colorectal Cancer in Type 2 Diabetes: A Large Population-Based Cohort Study

Wu Y, Meng M, Liu Y, Zeng R, Feng J, Lian Q, Ma Y, Zhang L, Huang W, Leung FW, Duan C, Sha W, Chen[...]

The Epidemiology of Atopic Dermatitis Among Adults and Adolescents with Alopecia Areata in the United States

Bunick CG, Armstrong AW, Grada A, Soliman AM, Li C, Bristow CC, Khan IA, Lipiszko D, Silverberg JI, Issa NT, Mostaghimi A. The Epidemiology of[...]

Exploring depression treatment response by using polygenic risk scoring across diverse populations

Lapinska S, Pimplaskar A, Shi Z, Ding Y, Frydman-Gani C, Hou K, Venkateswaran V, Boulier K, Olde Loohuis LM, Pasaniuc B. Exploring depression treatment response[...]